Shandong Sino-Agri United BiotechnologyLtd Past Earnings Performance
Past criteria checks 0/6
Shandong Sino-Agri United BiotechnologyLtd's earnings have been declining at an average annual rate of -70.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 4.8% per year.
Key information
-70.1%
Earnings growth rate
-72.6%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 4.8% |
Return on equity | -11.5% |
Net Margin | -8.8% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Shandong Sino-Agri United Biotechnology Co.,Ltd (SZSE:003042) Held Back By Insufficient Growth Even After Shares Climb 28%
Nov 29Shandong Sino-Agri United Biotechnology Co.,Ltd (SZSE:003042) Held Back By Insufficient Growth Even After Shares Climb 28%
Nov 29Shandong Sino-Agri United Biotechnology Co.,Ltd's (SZSE:003042) Revenues Are Not Doing Enough For Some Investors
Apr 17Revenue & Expenses Breakdown
How Shandong Sino-Agri United BiotechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,853 | -163 | 165 | 78 |
30 Jun 24 | 1,774 | -213 | 186 | 94 |
31 Mar 24 | 1,616 | -231 | 189 | 94 |
31 Dec 23 | 1,681 | -192 | 193 | 98 |
30 Sep 23 | 1,781 | -68 | 176 | 93 |
30 Jun 23 | 1,819 | 20 | 164 | 98 |
31 Mar 23 | 2,019 | 66 | 151 | 101 |
01 Jan 23 | 1,933 | 73 | 162 | 104 |
30 Sep 22 | 1,951 | 107 | 188 | 110 |
30 Jun 22 | 1,826 | 118 | 169 | 95 |
31 Mar 22 | 1,679 | 104 | 167 | 78 |
01 Jan 22 | 1,625 | 99 | 153 | 74 |
30 Sep 21 | 1,579 | 69 | 170 | 59 |
30 Jun 21 | 1,515 | 50 | 136 | 58 |
31 Mar 21 | 1,584 | 103 | 159 | 65 |
31 Dec 20 | 1,568 | 104 | 157 | 65 |
31 Dec 19 | 1,367 | 147 | 240 | 61 |
31 Dec 18 | 1,413 | 244 | 179 | 71 |
31 Dec 17 | 1,122 | 106 | 147 | 52 |
30 Jun 17 | 1,089 | 109 | 171 | 0 |
31 Mar 17 | 1,020 | 91 | 158 | 0 |
31 Dec 16 | 952 | 73 | 146 | 0 |
31 Dec 15 | 907 | 84 | 124 | 0 |
Quality Earnings: 003042 is currently unprofitable.
Growing Profit Margin: 003042 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 003042 is unprofitable, and losses have increased over the past 5 years at a rate of 70.1% per year.
Accelerating Growth: Unable to compare 003042's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 003042 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 003042 has a negative Return on Equity (-11.46%), as it is currently unprofitable.